Allergic rhinitis

Results: 562



#Item
1Reduction of Allergy Symptoms by Molekule’s PECO AIR Purification By: Dr. Nikhil G. Rao Abstract: Exposure to airborne allergens and pollutants is linked to symptom severity for allergic rhinitis and

Reduction of Allergy Symptoms by Molekule’s PECO AIR Purification By: Dr. Nikhil G. Rao Abstract: Exposure to airborne allergens and pollutants is linked to symptom severity for allergic rhinitis and

Add to Reading List

Source URL: assets.molekule.com

Language: English - Date: 2017-05-15 14:58:29
    220160404_Anergis_Closes_CHF_5_Million_Financing_Round_Extension_to_Conduct_the_ATIBAR_Trial

    20160404_Anergis_Closes_CHF_5_Million_Financing_Round_Extension_to_Conduct_the_ATIBAR_Trial

    Add to Reading List

    Source URL: www.biomedvc.com

    Language: English - Date: 2016-04-04 05:01:38
    3Article ID: WMC005078  ISSNSensitization pattern to food and inhalant allergens in allergic patients from Jeddah city: Saudi Arabia

    Article ID: WMC005078 ISSNSensitization pattern to food and inhalant allergens in allergic patients from Jeddah city: Saudi Arabia

    Add to Reading List

    Source URL: www.webmedcentral.com

    Language: English - Date: 2016-08-04 06:26:44
    4Indoor Air 2008, 17-22 August 2008, Copenhagen, Denmark - Paper ID: 458  The perceived indoor climate in Swedish schools Kjell Andersson*, Inger Fagerlund and Wenche Aslaksen Department of Occupational and Environmental

    Indoor Air 2008, 17-22 August 2008, Copenhagen, Denmark - Paper ID: 458 The perceived indoor climate in Swedish schools Kjell Andersson*, Inger Fagerlund and Wenche Aslaksen Department of Occupational and Environmental

    Add to Reading List

    Source URL: ust.is

    Language: English - Date: 2016-07-01 15:11:55
    5Anergis Starts Phase II Dose Ranging Trial with Birch Pollen Allergy Vaccine AllerT − Dose assessment for upcoming Phase III trial EPALINGES, Switzerland, December 11, 2014 – Anergis, a company developing proprietary

    Anergis Starts Phase II Dose Ranging Trial with Birch Pollen Allergy Vaccine AllerT − Dose assessment for upcoming Phase III trial EPALINGES, Switzerland, December 11, 2014 – Anergis, a company developing proprietary

    Add to Reading List

    Source URL: www.biomedvc.com

    Language: English - Date: 2014-12-15 02:51:18
    620140205_Anergis Financing 2014_FINAL

    20140205_Anergis Financing 2014_FINAL

    Add to Reading List

    Source URL: www.biomedvc.com

    Language: English - Date: 2014-08-28 07:53:12
    7RAMPANT SEXISM IN THE GARDEN A horticulturalist warns that planting all male, litter-free gardens can wreak

    RAMPANT SEXISM IN THE GARDEN A horticulturalist warns that planting all male, litter-free gardens can wreak

    Add to Reading List

    Source URL: commonground.typepad.com

    Language: English - Date: 2008-08-28 16:00:23
    8Ambrosia  Ambrosia dumosa (A. Gray) Payne and others Asteraceae Ambrosi Dumosae herba seu flos

    Ambrosia Ambrosia dumosa (A. Gray) Payne and others Asteraceae Ambrosi Dumosae herba seu flos

    Add to Reading List

    Source URL: www.passiflora-press.com

    Language: English - Date: 2015-06-17 22:17:48
    9Corporate Presentation January 2016 A world-class specialty biopharma business

    Corporate Presentation January 2016 A world-class specialty biopharma business

    Add to Reading List

    Source URL: www.circassia.com

    Language: English - Date: 2016-01-11 11:48:32
    10Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD)

    Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD)

    Add to Reading List

    Source URL: www.circassia.com

    Language: English - Date: 2015-11-05 09:21:27